Cargando…
Phosphorylation State-Dependent High Throughput Screening of the c-Met Kinase
High-throughput screening (HTS) of ~50,000 chemical compounds against phosphorylated and unphosphorylated c-Met, a tyrosine kinase receptor for hepatocyte growth factor (HGF), was carried out in order to compare hit rates, hit potencies and also to explore scaffolds that might serve as potential lea...
Autores principales: | Behshad, Elham, Klabe, Ronald M., Margulis, Alexander, Becker-Pasha, Mary, Rupar, Mark J., Collier, Paul, Liu, Phillip C., Hollis, Gregory F., Burn, Timothy C., Wynn, Richard |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Bentham Open
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2885599/ https://www.ncbi.nlm.nih.gov/pubmed/20556206 http://dx.doi.org/10.2174/1875397301004010027 |
Ejemplares similares
-
INCB054828 (pemigatinib), a potent and selective inhibitor of
fibroblast growth factor receptors 1, 2, and 3, displays activity against
genetically defined tumor models
por: Liu, Phillip C. C., et al.
Publicado: (2020) -
Biophysical and structural characterization of the impacts of MET phosphorylation on tepotinib binding
por: Grädler, Ulrich, et al.
Publicado: (2023) -
Differential responses of MET activations to MET kinase inhibitor and neutralizing antibody
por: Kou, Jianqun, et al.
Publicado: (2018) -
Truncated RAF kinases drive resistance to MET inhibition in MET-addicted cancer cells
por: Petti, Consalvo, et al.
Publicado: (2014) -
Activating MET Kinase Rearrangements in Melanoma and Spitz Tumors
por: Yeh, Iwei, et al.
Publicado: (2015)